Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data.
MTLE
disease progression
duration of illness
event-based model
patient staging
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
01
06
2022
received:
21
01
2022
accepted:
01
06
2022
pubmed:
4
6
2022
medline:
12
8
2022
entrez:
3
6
2022
Statut:
ppublish
Résumé
Recent work has shown that people with common epilepsies have characteristic patterns of cortical thinning, and that these changes may be progressive over time. Leveraging a large multicenter cross-sectional cohort, we investigated whether regional morphometric changes occur in a sequential manner, and whether these changes in people with mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE-HS) correlate with clinical features. We extracted regional measures of cortical thickness, surface area, and subcortical brain volumes from T1-weighted (T1W) magnetic resonance imaging (MRI) scans collected by the ENIGMA-Epilepsy consortium, comprising 804 people with MTLE-HS and 1625 healthy controls from 25 centers. Features with a moderate case-control effect size (Cohen d ≥ .5) were used to train an event-based model (EBM), which estimates a sequence of disease-specific biomarker changes from cross-sectional data and assigns a biomarker-based fine-grained disease stage to individual patients. We tested for associations between EBM disease stage and duration of epilepsy, age at onset, and antiseizure medicine (ASM) resistance. In MTLE-HS, decrease in ipsilateral hippocampal volume along with increased asymmetry in hippocampal volume was followed by reduced thickness in neocortical regions, reduction in ipsilateral thalamus volume, and finally, increase in ipsilateral lateral ventricle volume. EBM stage was correlated with duration of illness (Spearman ρ = .293, p = 7.03 × 10 From cross-sectional MRI, we reconstructed a disease progression model that highlights a sequence of MRI changes that aligns with previous longitudinal studies. This model could be used to stage MTLE-HS subjects in other cohorts and help establish connections between imaging-based progression staging and clinical features.
Identifiants
pubmed: 35656586
doi: 10.1111/epi.17316
pmc: PMC9540015
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2081-2095Subventions
Organisme : Medical Research Council
ID : MR/M00841X/1
Pays : United Kingdom
Organisme : NIBIB NIH HHS
ID : R01 EB015611
Pays : United States
Organisme : Department of Health
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG058854
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS065838
Pays : United States
Organisme : Medical Research Council
ID : MR/L016311/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH117601
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG059874
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS120976
Pays : United States
Organisme : NIH HHS
ID : S10 OD023696
Pays : United States
Organisme : Medical Research Council
ID : MR/S03546X/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH116147
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41 EB015922
Pays : United States
Organisme : Medical Research Council
ID : MR/N026063/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S00355X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T04294X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023152/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0802012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013998/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : RF1 MH123163
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS107739
Pays : United States
Investigateurs
Núria Bargalló
(N)
Emanuele Bartolini
(E)
Terence J O'Brien
(TJ)
Rhys H Thomas
(RH)
Informations de copyright
© 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Bioinformatics. 2001 Jun;17(6):520-5
pubmed: 11395428
Brain. 2020 Aug 1;143(8):2454-2473
pubmed: 32814957
Epilepsia. 2022 Aug;63(8):2081-2095
pubmed: 35656586
Brain. 2022 May 24;145(4):1285-1298
pubmed: 35333312
Ann Neurol. 2017 Feb;81(2):240-250
pubmed: 28009132
Epilepsia. 2008 May;49(5):741-57
pubmed: 18177358
Brain. 2013 Oct;136(Pt 10):3140-50
pubmed: 24014518
Neuroimage. 2006 Sep;32(3):1070-9
pubmed: 16872843
Brain. 2014 Sep;137(Pt 9):2564-77
pubmed: 25012224
Ann Clin Transl Neurol. 2020 May;7(5):722-732
pubmed: 32367696
J Int Neuropsychol Soc. 2008 May;14(3):384-93
pubmed: 18419837
Epilepsia. 2018 May;59(5):982-992
pubmed: 29637549
Epilepsy Behav. 2007 Nov;11(3):442-9
pubmed: 17996640
Hum Brain Mapp. 2019 Jun 1;40(8):2390-2398
pubmed: 30666753
Neurology. 2009 Sep 15;73(11):834-42
pubmed: 19752449
Neurology. 2005 Jul 26;65(2):223-8
pubmed: 16043790
Ann Neurol. 2003 Mar;53(3):312-24
pubmed: 12601699
Neurology. 2013 Nov 19;81(21):1840-7
pubmed: 24142475
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
JAMA Neurol. 2019 Oct 01;76(10):1230-1239
pubmed: 31260004
Neurology. 2015 May 5;84(18):1846-53
pubmed: 25854868
Epilepsia. 2016 Apr;57(4):621-9
pubmed: 26865066
Front Neurol. 2020 Jul 02;11:622
pubmed: 32714274
Neuroimage. 2018 Feb 15;167:104-120
pubmed: 29155184
J Abnorm Soc Psychol. 1962 Sep;65:145-53
pubmed: 13880271
Neurology. 2013 Jul 9;81(2):144-9
pubmed: 23749796
Epilepsia. 2021 Jan;62(1):6-24
pubmed: 33236784
Neurology. 2017 Aug 1;89(5):506-516
pubmed: 28687722
Sci Rep. 2019 Feb 20;9(1):2418
pubmed: 30787303
Neuroimage. 2012 Apr 15;60(3):1880-9
pubmed: 22281676
Epilepsia. 2012 Jun;53(6):995-1003
pubmed: 22510097
Brain. 2016 Sep;139(Pt 9):2431-40
pubmed: 27357350
Brain. 2018 Jun 1;141(6):1665-1677
pubmed: 29741648
Hum Brain Mapp. 2020 May 29;:
pubmed: 32468614
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Brain. 2020 Dec 5;143(11):3262-3272
pubmed: 33179036
Neurology. 2009 May 19;72(20):1747-54
pubmed: 19246420
Epilepsia. 2020 Apr;61(4):735-746
pubmed: 32196657
Neurology. 2019 Jan 22;92(4):e351-e358
pubmed: 30587513
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Arch Neurol. 2002 Dec;59(12):1891-4
pubmed: 12470176
Hum Brain Mapp. 2017 Feb;38(2):753-766
pubmed: 27677885
Epilepsia. 2008 May;49(5):794-803
pubmed: 18266751
Neuroimage Clin. 2021;31:102765
pubmed: 34339947
Brain. 2018 Feb 1;141(2):391-408
pubmed: 29365066
Neuroimage Clin. 2021;29:102550
pubmed: 33418173
AJNR Am J Neuroradiol. 2014 Jan;35(1):77-83
pubmed: 23868151
Nat Methods. 2021 Jul;18(7):698-700
pubmed: 34194050
Neuroimage. 2004 Oct;23(2):717-23
pubmed: 15488421
Brain. 2021 Apr 12;144(3):975-988
pubmed: 33543247
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
Alzheimers Dement. 2020 Jul;16(7):965-973
pubmed: 32489019
Neurology. 2012 Jan 10;78(2):129-36
pubmed: 22205759